Clinical and molecular characterisation of Bardet-Biedl syndrome in consanguineous populations: the power of homozygosity mapping

J Med Genet. 2010 Apr;47(4):236-41. doi: 10.1136/jmg.2009.070755. Epub 2009 Oct 26.

Abstract

Bardet-Biedl syndrome (BBS) is a ciliopathy with pleiotropic effect that manifests primarily as renal insufficiency, polydactyly, retinal dystrophy and obesity. The current phenotype-genotype correlation is insufficient to predict the likely causative mutation that makes sequencing of all 14 BBS genes an often necessary but highly complicated way to identify the underlying genetic defect in affected patients. In this study, homozygosity mapping is shown as a robust approach that is highly suited for genetically heterogeneous autosomal recessive disorders in populations in which consanguinity is prevalent. This approach allowed us to quickly identify seven novel mutations in seven families with BBS. Some of these mutations would have been missed by unguided routine sequencing, which suggests that missed mutations in known BBS genes could be more common than previously thought. This study, the largest to date on Saudi BBS families, also revealed interesting phenotypic aspects of BBS, including the first report of non-syndromic retinitis pigmentosa as a novel BBS phenotype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Bardet-Biedl Syndrome / diagnosis
  • Bardet-Biedl Syndrome / genetics*
  • Base Sequence
  • Child
  • Child, Preschool
  • Chromosome Mapping
  • Consanguinity*
  • DNA Mutational Analysis / methods*
  • Female
  • Homozygote
  • Humans
  • Male
  • Microtubule-Associated Proteins
  • Molecular Sequence Data
  • Oligonucleotide Array Sequence Analysis
  • Pedigree
  • Proteins / genetics
  • Sequence Alignment

Substances

  • Bbs1 protein, human
  • Microtubule-Associated Proteins
  • Proteins